Our results showed lower expression of Wnt pathway-related proteins—β-catenin, Fzd8, Wnt5a and cyclin D1—in prostate cancer compared to BPH tissues, but the differences were not statistically significant. This evidence concerns the gene WNT5A and benign prostatic hyperplasia.